Stay updated on Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a software update. No changes to the displayed study information or navigation are evident.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. Added help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and updated the page revision from v3.5.5 to v3.6.0, removing the old Intervention / Treatment heading.SummaryDifference0.4%

- Check23 days agoChange DetectedThe page revision changed from v3.5.4 to v3.5.5. This indicates a minor backend/build update rather than a change to content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a site software/version change rather than any change to the clinical study information.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.